Today

Agents

Chat

Arena

Discover

More

App

Immunovant target price raised to $61 from $59

IMVT•2026-11-10

Leerink Partners raised its target price for Immunovant to $61 from $59.

Related News

P

Power Solutions International secures multiyear engine supply commitment from HD Construction Equipment

PSIX•2026-11-10

Rocket Lab Corp: Piper Sandler cuts target price to $58 from $83

RKLB•2026-11-10

US sues Lyft, alleges discrimination against disabled riders

LYFT•2026-11-10

US oil to retest support at $85.31

USO•2026-11-10

Natural Gas Services Group forecasts 2026 adjusted EBITDA of $105 million-$108 million

NGS•2026-11-10

Immunovant target price raised to $61 from $59 - IMVT News | Rallies